Pharmacokinetics of fenoterol in pregnant and nonpregnant women
- 1 October 1993
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 45 (3) , 275-277
- https://doi.org/10.1007/bf00315396
Abstract
The pharmacokinetics of the β2-adrenergic drug fenoterol, which is used as a tocolytic agent in pregnancy, has been investigated in pregnant (n=9) and nonpregnant (n=5) women during a constant rate intravenous infusion. Clearance and mean residence time were found to be 1990 (1879/2220; Median, Q25/Q75) ml/min and 9.2 (8.0/14.0) min in the pregnant and 2126 (1915/2130) ml/min and 16.6 (16.5/32.1) min in the nonpregnant women, respectively. In addition, fenoterol clearance was estimated in 88 women from a single blood sample collected at steady state during IV therapy and the effect of gestational age on clearance was studied. Clearance displayed large inter-individual variation. There was no apparent correlation between clearance and gestational age. We conclude that there is no need to adjust the dose on pharmacokinetic grounds in the course of pregnancy.Keywords
This publication has 6 references indexed in Scilit:
- The pharmacokinetics of theβ 2-adrenoceptor agonist fenoterol in healthy womenEuropean Journal of Clinical Pharmacology, 1992
- RADIOIMMUNOLOGICAL DETERMINATION OF FENOTEROL .2. ANTISERUM AND TRACER FOR THE DETERMINATION OF FENOTEROL1990
- Angewandte StatistikPublished by Springer Nature ,1984
- Drug Kinetics in PregnancyClinical Pharmacokinetics, 1977
- A physiological approach to hepatic drug clearanceClinical Pharmacology & Therapeutics, 1975
- [Comparative pharmacokinetic studies on fenoterol-hydrobromide in rat, dog and man].1972